期刊文献+

间充质干细胞治疗椎间盘退变的研究进展 被引量:1

Research progress of mesenchymal stem cell therapy for regeneration of degenerated intervertebral discs
原文传递
导出
摘要 下腰痛已严重影响了人们的工作和生活,带来了严重的经济负担和社会负担。下腰痛主要是由椎间盘退变性疾病引起,保守治疗和手术治疗是目前临床上治疗椎间盘退变的常用方法,但这些方法仅限于缓解症状,而无法从根本上扭转椎间盘退变。人们已经开始关注通过恢复椎间盘细胞的数量和功能,从而实现生物学修复椎间盘退变的目的。间充质干细胞可分化为髓核样细胞,这为利用干细胞治疗椎间盘退变提供了种子细胞。间充质干细胞与椎间盘细胞的共培养技术也为此提供了可行的方法。目前这种方法也仅限于临床前研究,还有许多问题需要解决,例如:如何确定髓核细胞表型、如何避免干细胞的渗漏和肿瘤形成等。 Intervertebral disc degeneration(IVD) represents the main cause of the low-back pain that affects the majority of the adult population, and causes major social and economic costs. Physical therapy and spinal fusion as the major treatment for IVD degeneration only can relieve symptoms, but can not reverse IVD degeneration. People had begun to pay attention to the number and functional recovery of intervertebral disc cells, to achieve the goal of reversing the degeneration of intervertebral disc. Adult mesenchymal stem cells(MSC) can be differentiated into nucleus pulposus like cells, which provide seed cells for the treatment of IVD. MSC and intervertebral disc cells co-culture technology also provides a feasible method. At present, the use of MSC for IVD degeneration is limited to pre-clinical research, and many problems need to be solved. For example, how to determine the phenotype of nucleus pulposus cells, how to avoid the leakage of stem cells and tumor formation.
出处 《中华临床医师杂志(电子版)》 CAS 2016年第18期2766-2771,共6页 Chinese Journal of Clinicians(Electronic Edition)
基金 国家自然科学基金青年基金项目(81401830) 中国博士后科学基金二等资助(2015M571714) 江苏省自然科学基金青年基金项目(BK20140496)
关键词 MSC 椎间盘退变 细胞治疗 Mesenchymal stem cells Intervertebral disc degeneration Cell-based therapy
  • 相关文献

参考文献2

二级参考文献14

  • 1ênio José Bassi,Carlos Alberto Mayora Aita,Niels Olsen Saraiva Camara.Immune regulatory properties of multipotent mesenchymal stromal cells:Where do we stand?[J].World Journal of Stem Cells,2011,3(1):1-8. 被引量:27
  • 2Ye, Zhou,Wang, Yan,Xie, Hai-Yang,Zheng, Shu-Sen.Immunosuppressive effects of rat mesenchymal stem cells:involvement of CD4^+ CD25^+ regulatory T cells[J].Hepatobiliary & Pancreatic Diseases International,2008,7(6):608-614. 被引量:15
  • 3Kentaro Akiyama,Chider Chen,DanDan Wang,Xingtian Xu,Cunye Qu,Takayoshi Yamaza,Tao Cai,WanJun Chen,Lingyun Sun,Songtao Shi.Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell Apoptosis[J]. Cell Stem Cell . 2012 (5)
  • 4Lindolfo da Silva Meirelles,Aparecida Maria Fontes,Dimas Tadeu Covas,Arnold I. Caplan.Mechanisms involved in the therapeutic properties of mesenchymal stem cells[J]. Cytokine and Growth Factor Reviews . 2009 (5)
  • 5Ke Chen,Ding Wang,Wei Ting Du,Zhi-Bo Han,He Ren,Ying Chi,Shao Guang Yang,Delin Zhu,Francis Bayard,Zhong Chao Han.Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE 2 -dependent mechanism[J].Clinical Immunology.2010(3)
  • 6YaojiongWu,LiwenChen,Paul G.Scott,Edward E.Tredget.Mesenchymal Stem Cells Enhance Wound Healing Through Differentiation and Angiogenesis[J].STEM CELLS.2009(10)
  • 7Guangwen Ren,Liying Zhang,Xin Zhao,Guangwu Xu,Yingyu Zhang,Arthur I. Roberts,Robert Chunhua Zhao,Yufang Shi.Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide[J].Cell Stem Cell.2008(2)
  • 8Dimitrios Karussis,Ibrahim Kassis,Basan Gowda S. Kurkalli,Shimon Slavin.Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): A proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases[J].Journal of the Neurological Sciences.2007(1)
  • 9J.Stagg.Immune regulation by mesenchymal stem cells: two sides to the coin[J].Tissue Antigens.2006(1)
  • 10Margaret E. Groh,Basabi Maitra,Emese Szekely,Omer N. Ko?.Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells[J].Experimental Hematology.2005(8)

共引文献31

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部